2009
DOI: 10.1055/s-0028-1109686
|View full text |Cite
|
Sign up to set email alerts
|

Vergleichende Untersuchung zur Therapie des evaporativen trockenen Auges

Abstract: Both therapies improved evaporative dry eye, but patients on phospholipid-liposomal eye spray demonstrated greater clinical benefit from their therapy, particularly regarding the degree of inflammation of the lid margins as well as the grade of LIPCOF. When compared to hyaluronate artificial tears, NIBUT more than doubled in the phospholipid-liposome eye spray group. Clinical severity of dry eye is more pronounced when evaporative dry eye and aqueous tear deficiency coincide. A combination of the phospholipid-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
5
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 20 publications
2
5
0
Order By: Relevance
“…Our results are in good agreement with the results of Korb and others [11][12][13][14][15][16][17] that artificial tears containing phosphatidylcholine and other phospholipids strongly increase the thickness and the non-invasive break-up time of TF in vivo.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Our results are in good agreement with the results of Korb and others [11][12][13][14][15][16][17] that artificial tears containing phosphatidylcholine and other phospholipids strongly increase the thickness and the non-invasive break-up time of TF in vivo.…”
Section: Discussionsupporting
confidence: 92%
“…At present they are used as compounds of artificial tears (Tears Again, Soothe, Refresh Dry Eye Therapy, FreshKote, Refresh Endura) targeted to replenish the TF lipid layer of patients with Dry Eye Syndrome. Although the number of lipid-containing artificial tears on the market still remains relatively limited, in vivo studies demonstrated that formulations containing phospholipids and other PLs significantly increase the non-invasive break-up time of TF in laboratory animals and humans [11][12][13][14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…Similar to the findings by Böhm et al [6], the safety and tolerability of the treatment investigated here can be assessed as good, since no treatment-related adverse events or serious adverse events occurred. These results are consistent with those from previous studies evaluating the effect of LS for dry eye [8, 10] and with findings from studies assessing liposomal nasal spray [13, 15]. …”
Section: Discussionsupporting
confidence: 83%
“…Numbers above the arrows represent the different studies on a time scale of their duration in months. 1: current results, 2: Höh et al [ 21 ], 3: group 1 and 2 of Dausch et al [ 20 ], 4: Khaireddin et al [ 22 ], 5: Lee et al [ 23 ].…”
Section: Discussionmentioning
confidence: 99%